Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Mammalian cells fuel their growth and proliferation through the catabolism of two main substrates: glucose and glutamine. Most of the remaining metabolites taken up by proliferating cells are not catabolized, but instead are used as building blocks during anabolic macromolecular synthesis. Investigations of phosphoinositol 3-kinase (PI3K) and its downstream effector AKT have confirmed that these oncogenes play a direct role in stimulating glucose uptake and metabolism, rendering the transformed cell addicted to glucose for the maintenance of survival. In contrast, less is known about the regulation of glutamine uptake and metabolism. Here, we report that the transcriptional regulatory properties of the oncogene Myc coordinate the expression of genes necessary for cells to engage in glutamine catabolism that exceeds the cellular requirement for protein and nucleotide biosynthesis. A consequence of this Myc-dependent glutaminolysis is the reprogramming of mitochondrial metabolism to depend on glutamine catabolism to sustain cellular viability and TCA cycle anapleurosis. The ability of Myc-expressing cells to engage in glutaminolysis does not depend on concomitant activation of PI3K or AKT. The stimulation of mitochondrial glutamine metabolism resulted in reduced glucose carbon entering the TCA cycle and a decreased contribution of glucose to the mitochondrial-dependent synthesis of phospholipids. These data suggest that oncogenic levels of Myc induce a transcriptional program that promotes glutaminolysis and triggers cellular addiction to glutamine as a bioenergetic substrate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“recent studies show that some tumors predominantly use glutamine under hypoxia or conditions mimicking hypoxia such as electron transport chain inhibition through reductive carboxylation for biosynthetic needs (Yang et al., 2014; Wise et al., 2008).”
From Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism (2016) · cites this paper as Wise et al., 2008
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“genes involved in glutamine metabolism appear to be under both the direct and indirect transcriptional control of the MYC protein (32, 33)”
From Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation (2009) · cites this paper as [32]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The transcription factor c-myc, which is upregulated in proliferating cells and is frequently targeted by amplification in various tumor types, is a principal driver of glutamine utilization by proliferating cells”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Wise et al., 2008
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Glutamine anaplerosis is critical for meeting the energetic requirements of proliferative cells, such as T cells during the transition from quiescent naïve T cells to effector cells, and in cancers, particularly with MYC elevation.32,36,37”
From The multifaceted contributions of mitochondria to cellular metabolism (2018) · cites this paper as [37]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It has long been established that Myc activation upregulates glutamine metabolism [79,80], increasing glutamine flux by upregulating the glutamine transporter (ASCT2) and glutaminase-1, thus increasing glutamine conversion to glutamate [81].”
From HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells (2021) · cites this paper as [80]
Experimental — accuracy not yet measured
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425 · cited 1×
“M cancer cell lines depend on a high rate of glucose uptake and metabolism to maintain their viability despite being maintained in an oxygen-replete environment (1).”
BackgroundOn Respiratory Impairment in Cancer Cells
Warburg, O. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,468
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622 · cited 6×
“Recently, we reported that glioma cells can exhibit glutamine uptake and metabolism that exceeds the cell’s use of glutamine for protein and nucleotide biosynthesis (12).”
BackgroundMethodInfluentialSelf-citationBen-Porath, I., Thomson, M. W., Carey, V. J., Ge, R., Bell, G. W., Regev, A., & Weinberg, R. A. (2008) · Nature Genetics · doi:10.1038/ng.127 · Cited by 2,523 · cited 1×
“Another oncogene associated with a poor prognosis in glial tumors is Myc (14).”
BackgroundTumor cell metabolism: cancer's Achilles' heel
Kroemer, G., & Pouyssegur, J. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.05.005 · Cited by 2,337
Dalla-Favera, R., Bregni, M., Erikson, J., Patterson, D., Gallo, R. C., & Croce, C. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.24.7824 · Cited by 1,773 · cited 1×
“Myc-activation/amplification is one of the most common oncogenic events observed in a wide variety of cancers and is known to drive the progression of human lymphomas (28, 29), neuroblastoma (30), and small cell lung cancer (31).”
Backgroundc-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism
Dang, C. V. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.1 · Cited by 1,715 · cited 1×
“Myc’s transforming properties depend on its ability to bind to DNA and modify gene transcription (16).”
BackgroundNutrition Needs of Mammalian Cells in Tissue Culture
Eagle, H. (1955) · Science · doi:10.1126/science.122.3168.501 · Cited by 1,619 · cited 1×
“In addition to glucose, glutamine can be an essential nutrient for cell growth and viability (8, 9).”
BackgroundAkt Stimulates Aerobic Glycolysis in Cancer Cells
Elstrom, R. L., Bauer, D. E., Buzzai, M., Karnauskas, R., Harris, M. H., Plas, D. R., Zhuang, H., Cinalli, R. M., Alavi, A., Rudin, C. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2904 · Cited by 1,454 · cited 3×
“Recent studies have suggested that activating mutations in phosphoinositol 3-kinase (PI3K) and its downstream effector AKT induce the transformed cell to take up glucose in excess of its bioenergetic needs (5).”
BackgroundSelf-citationTaub, R., Kirsch, I., Morton, C., Lenoir, G., Swan, D., Tronick, S., Aaronson, S., & Leder, P. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.24.7837 · Cited by 1,422 · cited 1×
“Myc-activation/amplification is one of the most common oncogenic events observed in a wide variety of cancers and is known to drive the progression of human lymphomas (28, 29), neuroblastoma (30), and small cell lung cancer (31).”
BackgroundSchwab, M., Alitalo, K., Klempnauer, K.-H., Varmus, H. E., Bishop, J. M., Gilbert, F., Brodeur, G., Goldstein, M., & Trent, J. (1983) · Nature · doi:10.1038/305245a0 · Cited by 1,407 · cited 1×
“Myc-activation/amplification is one of the most common oncogenic events observed in a wide variety of cancers and is known to drive the progression of human lymphomas (28, 29), neuroblastoma (30), and small cell lung cancer (31).”
BackgroundDeficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells
Yuneva, M., Zamboni, N., Oefner, P., Sachidanandam, R., & Lazebnik, Y. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200703099 · Cited by 690 · cited 2×
“(23) have reported that some, but not all, Myc transformants were dependent on glutamine.”
BackgroundL-myc, a new myc-related gene amplified and expressed in human small cell lung cancer
Nau, M. M., Brooks, B. J., Battey, J., Sausville, E., Gazdar, A. F., Kirsch, I. R., McBride, O. W., Bertness, V., Hollis, G. F., & Minna, J. D. (1985) · Nature · doi:10.1038/318069a0 · Cited by 665 · cited 1×
“Myc-activation/amplification is one of the most common oncogenic events observed in a wide variety of cancers and is known to drive the progression of human lymphomas (28, 29), neuroblastoma (30), and small cell lung cancer (31).”
BackgroundDrosophila myc Regulates Cellular Growth during Development
Johnston, L. A., Prober, D. A., Edgar, B. A., Eisenman, R. N., & Gallant, P. (1999) · Cell · doi:10.1016/s0092-8674(00)81512-3 · Cited by 648 · cited 1×
“At lower levels of expression, Myc-induced increases in protein synthesis and cell growth will also stimulate the incorporation of glutamine into newly synthesized proteins (24, 25).”
BackgroundMyc Stimulates Nuclearly Encoded Mitochondrial Genes and Mitochondrial Biogenesis
Li, F., Wang, Y., Zeller, K. I., Potter, J. J., Wonsey, D. R., O'Donnell, K. A., Kim, J.-W., Yustein, J. T., Lee, L. A., & Dang, C. V. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.14.6225-6234.2005 · Cited by 614 · cited 1×
“Despite this, Myctransformed cells display an increased mitochondrial mass and increased rate of O2 consumption (21).”
BackgroundAkt Maintains Cell Size and Survival by Increasing mTOR-dependent Nutrient Uptake
Edinger, A. L., & Thompson, C. B. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.01-12-0584 · Cited by 589 · cited 2×
“Previous work has demonstrated that the PI3K/AKT pathway can regulate the expression and surface translocation of a variety of nutrient transporters (5, 13).”
BackgroundSelf-citationATP citrate lyase is an important component of cell growth and transformation
Bauer, D. E., Hatzivassiliou, G., Zhao, F., Andreadis, C., & Thompson, C. B. (2005) · Oncogene · doi:10.1038/sj.onc.1208773 · Cited by 537 · cited 2×
“Previous studies have suggested that proliferating nontransformed cells maintain de novo phospholipid biosynthesis from glucose (7).”
BackgroundSelf-citationLum, J. J., Bui, T., Gruber, M., Gordan, J. D., DeBerardinis, R. J., Covello, K. L., Simon, M. C., & Thompson, C. B. (2007) · Genes & Development · doi:10.1101/gad.1529107 · Cited by 429 · cited 3×
“The resulting high rate of glycolytic metabolism leads to the conversion of mitochondria into synthetic organelles that support glucose-dependent lipid synthesis and nonessential amino acid production (6, 7).”
BackgroundMethodSelf-citationMoreadith, R. W., & Lehninger, A. L. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)82128-0 · Cited by 414
c-Myc enhances protein synthesis and cell size during B lymphocyte development
Iritani, B. M., & Eisenman, R. N. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13180 · Cited by 364 · cited 1×
“At lower levels of expression, Myc-induced increases in protein synthesis and cell growth will also stimulate the incorporation of glutamine into newly synthesized proteins (24, 25).”
Backgroundüber den Stoffwechsel der Carcinomzelle
Warburg, O. (1925) · Klinische Wochenschrift · doi:10.1007/bf01726151 · Cited by 253
DeBerardinis, R. J., Lum, J. J., & Thompson, C. B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608372200 · Cited by 221 · cited 3×
“pholipids were collected using TLC (33).”
MethodSelf-citationEvidence for rearrangement, amplification, and expression of c-myc in a human glioblastoma.
Trent, J., Meltzer, P., Rosenblum, M., Harsh, G., Kinzler, K., Mashal, R., Feinberg, A., & Vogelstein, B. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.2.470 · Cited by 172 · cited 1×
“SF188 cells were originally isolated from a patient whose tumor displayed amplification of Myc (15).”
BackgroundThe oncogene c-Myc coordinates regulation of metabolic networks to enable rapid cell cycle entry
Morrish, F., Neretti, N., Sedivy, J. M., & Hockenbery, D. M. (2008) · Cell Cycle · doi:10.4161/cc.7.8.5739 · Cited by 132
Glutamine, cancer, and its therapy
Klimberg, V., & McClellan, J. L. (1996) · The American Journal of Surgery · doi:10.1016/s0002-9610(96)00217-6 · Cited by 131 · cited 1×
“In cancer patients, some tumors have been reported to consume such an abundance of glutamine that they depress plasma glutamine levels (10, 11).”
BackgroundTumor induction by the c-Myc target genes rcl and lactate dehydrogenase A.
Lewis, B. C., Prescott, J. E., Campbell, S. E., Shim, H., Orlowski, R. Z., & Dang, C. V. (2000) · PubMed · Cited by 104
Thomas‐Tikhonenko, A., Viard, I., Dews, M., Wehrli, P., Sevignani, C., Yu, D., Ricci, S., El‐Deiry, W. S., Aronow, B. J., Kaya, G., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1953 · Cited by 70 · cited 1×
“To address this question, immortalized MEF that stably express a 4-hydroxy tamoxifen-inducible MycER construct (17) were analyzed to study the effects of Myc activation on glutamine metabolism.”
MethodGlutamine metabolism in Ehrlich ascites-carcinoma cells
COLES, N., & JOHNSTONE, R. (1962) · Biochemical Journal · doi:10.1042/bj0830284 · Cited by 67 · cited 1×
“In addition to glucose, glutamine can be an essential nutrient for cell growth and viability (8, 9).”
BackgroundBCL2 Is a Downstream Effector of MIZ-1 Essential for Blocking c-MYC-induced Apoptosis
Patel, J. H., & McMahon, S. B. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609138200 · Cited by 64 · cited 1×
“performed as previously described (6, 12, 33, 34).”
MethodSelf-citationInfluence of Progressive Tumor Growth on Glutamine Metabolism in Skeletal Muscle and Kidney
Chen, M. K., Espat, N. J., Bland, K. I., Copeland, E. M., & Souba, W. W. (1993) · Annals of Surgery · doi:10.1097/00000658-199306000-00007 · Cited by 62 · cited 1×
“In cancer patients, some tumors have been reported to consume such an abundance of glutamine that they depress plasma glutamine levels (10, 11).”
BackgroundDetection of Resistance to Imatinib by Metabolic Profiling
Serkova, N. J., & Boros, L. (2005) · American Journal of PharmacoGenomics · doi:10.2165/00129785-200505050-00002 · Cited by 59 · cited 1×
“However, recent evidence suggests that transformed cells exhibiting aerobic glycolysis derive the majority of their ribose biosynthesis through the nonoxidative arm of the pentose phosphate shunt (27).”
BackgroundBode, B. P., & Souba, W. W. (1994) · Annals of Surgery · doi:10.1097/00000658-199410000-00001 · Cited by 48 · cited 3×
“After incubation, the medium was aspirated, and cells were washedthreetimeswithunlabeledmedium,afterwhichcellswere lysedwith200 l of a 0.2%SDS/0.2N NaOH solution, incubated for 1 h, neutralized with 10 l of 2N HCl, and analyzed with a beta scintillation counter (PerkinElmer Life Sciences) (32).”
MethodInfluentialAlanine Metabolism in the Perfused Rat Liver
Brosnan, J. T., Brosnan, M. E., Yudkoff, M., Nissim, I., Daikhin, Y., Lazarow, A., Horyn, O., & Nissim, I. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103890200 · Cited by 35 · cited 1×
“An aliquot was used to determine isotopic enrichment in NH3 with published methods (35).”
MethodSelf-citationAminooxyacetate is not an adequate differential inhibitor of aspartate aminotransferase isoenzymes.
Rej, R. (1977) · Clinical Chemistry · doi:10.1093/clinchem/23.8.1508 · Cited by 31 · cited 1×
“Although AOA is a wellcharacterized inhibitor of the transaminases (19), a chemical inhibitor can have nonspecific effects on the viability of cells.”
BackgroundBiaglow, J. E., Ayene, I. S., Koch, C. J., Donahue, J., Stamato, T. D., & Tuttle, S. W. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3024 · Cited by 30 · cited 1×
“It has long been believed that the major source of NADPH production during cell growth occurs through the oxidative arm of the pentose phosphate shunt (26).”
Background
Cited by
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Self-citationThe emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926
Self-citationRegulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744
Otto Warburg's contributions to current concepts of cancer metabolism
Koppenol, W. H., Bounds, P. L., & Dang, C. V. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3038 · Cited by 3,427
Metadata
- Authors
- Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., & Thompson, C. B.
- Affiliations
- Abramson Cancer Center (US)
- The University of Texas Southwestern Medical Center (US)
- Sidney Kimmel Cancer Center (US)
- Children's Hospital of Philadelphia (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2008-12-02
- Volume
- 105
- Issue
- 48
- Pages
- 18782-18787
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2596212
- OpenAlex
- W2055255976
- Cited by
- 2,001
- References
- 35
- Citations by year
- 2026: 64 · 2025: 78 · 2024: 118 · 2023: 133 · 2022: 123 · 2021: 145 · 2020: 139 · 2019: 142 · 2018: 126 · 2017: 133 · 2016: 139 · 2015: 124 · 2014: 144 · 2013: 103 · 2012: 109
- FWCI
- 20.35
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Cancer Research Institute
- Pennsylvania Department of Health
- National Institutes of Health (HD 26979)
- National Cancer Institute
- National Institute of Diabetes and Digestive and Kidney Diseases (K08DK072565)
- National Institute of Neurological Disorders and Stroke (P01NS054900, NS054900)
- National Center for Research Resources (M01RR000240)
- Abramson Family Cancer Research Institute
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P30HD026979, HD 26979)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- c-Myc, glutaminolysis, glutamine addiction, mitochondrial metabolism, transcriptional regulation, phosphatidylinositol 3-kinase, Akt, glucose metabolism, phospholipid synthesis
- MeSH terms
- Animals, Cell Line, Energy Metabolism, Fibroblasts, Gene Expression Regulation, Glucose, Glutamine, Humans, Mitochondria, Transcription, Genetic, Signal Transduction, Proto-Oncogene Proteins c-myc, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-akt, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.